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Testing a Model of Consultation-based Reassurance and
Back Pain Outcomes With Psychological Risk as Moderator
A Prospective Cohort Study
Nicola Holt, PhD,* Gemma Mansell, PhD,† Jonathan C. Hill, PhD,†
and Tamar Pincus, PhD*
Objectives: Reassurance is an essential part of treatment for low
back pain (LBP), but evidence on effective methods to deliver
reassurance remains scarce. The interaction between consultation-
based reassurance and patients’ psychological risk is unknown.
Our objective was to investigate the relationship between
consultation-based reassurance and clinical outcomes at follow-up,
in people with and without psychological risk.
Methods: We tested the associations between speciﬁc reassurance
components (data gathering, relationship building, generic reas-
surance, and cognitive reassurance), patients’ psychological risk (the
presence of depression, anxiety, catastrophizing, or fear-avoidance),
and postconsultation outcomes including, satisfaction and enable-
ment, disability, pain, and mood at 3-month follow-up.
Results: Adjusted linear regression models using data from patients
who had recently consulted for LBP in primary care (n= 142 in 43
practices) indicated that all reassurance components were strongly
associated with increased satisfaction, whereas generic reassurance
was signiﬁcantly associated with postconsultation enablement.
Generic reassurance was also associated with lower pain at
3 months, whereas cognitive reassurance was associated with
increased pain. A signiﬁcant interaction was observed between
generic reassurance and psychological risk for depression at
3 months: high rates of generic reassurance were associated with
lower depression in low-risk patients, but with higher rates of
depression for high-risk groups.
Discussion: The ﬁndings support the hypothesis that different com-
ponents of reassurance are associated with speciﬁc outcomes, and that
psychological risk moderates this relationship for depression. Clini-
cians reassuring behaviors might therefore have the potential to
improve outcomes in people with LBP, especially for patients with
higher psychological risk proﬁles.
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(Clin J Pain 2018;34:339–348)
Low back pain (LBP) remains highly prevalent and costlyworldwide.1 Reassurance is an essential part of treat-
ment, with key messages informing patients that serious
pathology is not present, the prognosis is usually good, that
they should remain active and that further tests are not
indicated.2 Although reassurance has the potential to
enhance self-management and reduce long-term disability,
evidence on effective methods to reassure patients with LBP
remains scarce and lacking conceptual clarity.
For clinicians practicing patient-centered care, with an
emphasis on shared decision-making, delivering effective
reassurance is particularly difﬁcult in the context of diag-
nostic uncertainty, and the limited number of evidence-
based treatment options. There is also no clear guidance on
the content of reassurance, beyond the message that most
patients have a good prognosis and that the presence of
serious pathology, in the absence of red ﬂag signs, is very
unlikely. At present there is little evidence of clinicians
providing either too much, or too little reassurance, or that
the type of reassurance given should be tailored according to
the patient’s clinical proﬁle.
In a systematic review of prospective cohorts of
patients attending primary care,3 high levels of patient-
perceived affective reassurance (generic positive messages
indicating empathy, conﬁdence, and optimism) from their
clinician was associated with worse symptom outcome in 3
high-quality studies,4–6 whereas greater perceived cognitive
reassurance (delivering information about etiology, prog-
nosis, and treatment) was linked to improved clinical out-
comes in 4 high-quality4,5,7 and 3 lower-quality studies.8–10
Subsequent studies in LBP11,12 suggest that affective reas-
surance includes both implicit and explicit behaviors (Fig. 1).
Information-eliciting and relationship-building behaviors provide
implicit reassurance, which aims to establish trust, elicit patients’
concerns, and convey the impression that the practitioner cares
and is listening,13 whereas explicit affective reassurance includes
generic statements (you should not be worried about anything
serious). Implicit reassurance is believed to be a precursor to the
uptake of explicit reassurance, through building of trust and
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rapport.12 Cognitive reassurance is always explicit (Here is what
I think is going on, and what I propose we do about it). This
distinction allows testing of (1) whether affective reassurance
(both implicit and explicit) reduces patients’ ability to take on
board information delivered,5 resulting in poorer outcomes, or
(2) in contrast, whether affective reassurance improves uptake of
information through forging trust between practitioner and
patients. A model of reassurance14 based on the evidence from
studies of persuasion argues that affective reassurance, and
especially generic reassurance, will enhance a sense of enable-
ment in the short term, but might actually result in worse out-
comes later, as patients have not acquired new information to
help control their problem.
Consultation-based reassurance in this context
describes practitioners’ behaviors during the consultation (to
differentiate from handing out written material or providing
information online) that aim to reduce patients’ concerns.
The relationships between consultation-based reassurance
and patients’ psychological risk is not known. Psychological
factors have been linked both to increased risk of a tran-
sition to chronicity and maintenance of chronic pain.15–19
Differences in patients’ individual characteristics (eg, levels
of mood, illness-related cognitions, and expectations) may
inﬂuence how they respond to different types of reassurance
at different points in their illness journey,20 and may also
affect practitioners’ behaviors. There is a need, therefore, to
examine whether psychological risk interacts with (moder-
ates) the impact of reassurance on outcomes.
This study aimed to test the associations between dif-
ferent aspects of patient-perceived reassurance following
primary care consultations for LBP and subsequent patient
outcomes, overall, and to explore whether there was a sig-
niﬁcant interaction (moderating effect) in this relationship
from patients’ psychological status.
The speciﬁc objective was to test how perceived reas-
surance behaviors relate to LBP outcomes. The following
hypotheses were tested:
(1) Global hypothesis—reassurance (all components) will be
associated with LBP outcomes, after accounting for
known predictors.
(2) Cognitive reassurance will be associated with improved
disability at 3 months, whereas affective reassurance will be
associated only with patients’ short-term satisfaction and
enablement, but not improved disability in the long term.
(3) Psychological risk status will moderate the relationship
between reassurance and outcomes.
METHODS
Design and Recruitment
This was a prospective observational cohort of patients
attending primary care general practice for LBP. In total, 43
general practices in the United Kingdom helped identify
patients who had attended for LBP in the previous month
(between October 2013 and April 2015). Participants were
identiﬁed through an electronic search of appropriate Read
(diagnostic) codes developed by an independent expert com-
pany and carried out by Nurse Practitioners at each practice.
Eligible patients were invited to take part in the study by letter,
with consent obtained to conduct a postal 3-month follow-up.
Ethical approval for this study was granted by the London City
and East National Research Ethics Service committee.
The inclusion and exclusion criteria were as follows:
Inclusions
 A general practitioner (GP) consultation for LBP within
the previous month.
 LBP without radiating leg pain and for whom self-
management is indicated (eg, patients were not referred).
 Adult patients (18 y and above).
Exclusions
 Red ﬂags for serious potential pathology (such as fracture
and inﬂammatory arthropathies).
 Cancer.
 Cauda equina and ankylosing spondylitis.
 Severe disability or end of life disorders.
 Pregnancy.
 Cognitive impairment or serious mental health problems,
which the GP considered could make patients vulnerable
and for whom study participation would be detrimental.
 Previous spinal surgery.
 Currently receiving or referred to secondary care (pain-
management programs, physiotherapy, etc.) for the same
problem.
 Unable to read and speak English.
 Those requiring further investigation or urgent medical
attention.
Measures
Patients received 1 questionnaire by post within a
month of their initial consultation (deﬁned as baseline), and
another (follow-up) after 3 months (Fig. 2).
Demographic data were collected at baseline. Partic-
ipants were also asked to report their back pain episode
duration using the following options: <1 month; 1 to
3 months; 4 to 6 months; 7 months to 3 years; > 3 years.
Participants were also asked if this was their ﬁrst episode of
back pain or not.
Predictor
Consultation-based Reassurance Questionnaire (baseline).
This 12-item questionnaire11 measures perceived reassur-
ance speciﬁc to consultations for LBP.
This questionnaire was developed through qualitative
interviews with patients and quantitative testing, using
Rasch modeling in 2 samples from the same population of
recent LBP consultations. It includes 4 subscales, each with
3 items: information gathering (eg, to what extent did your
FIGURE 1. Consultation-based reassurance and patient’ outcomes.
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doctor … encourage you to voice your concerns regarding
your symptoms); relationship building (eg, to what extent
did your doctor… show a genuine interest in your problem);
generic reassurance (eg, to what extent did your doctor …
tell you that everything would be ﬁne); and cognitive reas-
surance (eg, to what extent did your doctor … check you
understood the explanation he/she gave for your symptoms).
The response mode to each item describing a practitioner
behavior comprises a 0 to 7 Likert scale with the anchors
“not at all” to “a great deal.” Each subscale has a range of
possible scores from 0 to 21. The authors report that the
questionnaire performed with good content validity, con-
sistent responses across groups, and acceptable reliability.
Outcomes
Disability and Pain Intensity (Baseline and 3 mo).
Functional status (disability) was assessed using the Roland-
Morris Disability Questionnaire (RMDQ,21), which is a
well-validated measure of disability in LBP populations.22
Participants were asked to rate their pain intensity in
the previous week on the 11-point Pain Numeric Rating
Scale.22 The Numeric Rating Scale asks patients to rate their
pain from 0 (no pain) to 10 (worst possible pain).
Satisfaction and Enablement (Postconsultation). To
measure satisfaction, the Consultation Satisfaction Ques-
tionnaire (CSQ23) was used. The CSQ is a validated 9-item
questionnaire in which participants respond to statements
about how they felt about the consultation on a 5-point
scale from “strongly agree” to “strongly disagree.” The CSQ
is scored as a whole, and also provides subscales measuring
4 different aspects of satisfaction: general satisfaction; sat-
isfaction with professional care; satisfaction with the depth
of relationship; and satisfaction with perceived time. Ena-
blement was measured with the Patient Enablement
Instrument (PEI24) which has been validated for use in
primary care populations.25 The PEI consists of 6 items,
rated on a 3-point scale from either “much better” to “same
or less” or “much more” to “same or less” which concern
patients’ ability to cope with and manage their health/illness.
The Cronbach α values in the current population were 0.90
and 0.91 for the CSQ and PEI, respectively, suggested high
internal consistency.
Depression and Anxiety (3 mo). The Hospital Anxiety
and Depression Scale (HADS26) was used to assess partic-
ipants’ psychological mood outcomes. The HADS is a well-
established measure of anxiety and depression that has been
validated in both clinical and nonclinical populations, as
well as for use in primary care.27 It consists of 14 items, 7 of
which measure anxiety and the other 7 depression. Scores
from the HADS were entered as continuous variables, with
a higher score (of a possible 21 each) indicating higher
depression or anxiety. Participants are asked to give their
responses to the items based on how they have been feeling
in the past week. The Cronbach α values in this population
were 0.87 and 0.81 for anxiety and depression subscales,
respectively, suggesting high internal consistency.
Moderator
Psychosocial Risk (Baseline). Psychological risk was
determined using a modiﬁed STarT Back Tool.28 The
original STarT Back Tool includes 9 items: (1) referred leg
pain; (2) comorbid pain; (3) difﬁculties in walking; (4) dif-
ﬁculties in dressing; (5) fear of physical activity; (6) anxiety;
(7) pain catastrophising; (8) depressive mood; and (9) overall
impact of pain, with items (5) to (9) making up the psy-
chological subscale. To avoid the risk of incorporation bias,
as our primary outcomes were disability and pain, we
included only 4 items from the psychological subscale (5 to
8) that speciﬁcally relate to psychological risk. We excluded
item 9 on the overall impact from pain, because of the
ambiguity in this item representing a psychological risk
subgroup, rather than indicating a higher level of physical
complexity and compromised function.
A positive response to ≥ 3 of these 4 subscale items
was considered sufﬁcient to categorize an individual as
psychosocial “high-risk,” whereas a score of ≤ 2 classiﬁed
an individual as low-risk. We used this categorization
because there is evidence that each of the risk factors
independently increases the risk for chronicity.15,18,29 We
did not want to use the high-risk cut-off for the whole scale
(endorsing all 4 items), because we believed it would miss
people who clearly were experiencing psychological difﬁ-
culties. We therefore relaxed the cut-point to include those
who endorsed 3 items.
Potential Confounders
Demographic variables used as potential confounders
were age, sex, education, sex congruence of patient with
clinician length of current pain episode, and number of
previous consultation, pain intensity and disability, and
psychosocial risk score. Psychosocial risk score was dicho-
tomized into 2 groups, with a score of 0 to 2 indicating low
risk and a score of 3 to 4 indicating high risk.
In addition, to control for the effects of repeated con-
sultations, at the 3-month follow-up point participants,
reported the number of GP consultations they had had for
FIGURE 2. Flow chart of recruitment. LBP indicates low
back pain.
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this episode of LBP, and details of any other physicians they
had seen since their consultation.
Sample Size
We based the power calculation on the a-priori
hypothesis that those who perceived greater levels of cog-
nitive reassurance would show a 2.5-point difference on the
RMDQ in comparison with those who did not, taking into
account 80% power and an α of 5%. We assumed the SD of
disability would be equally distributed between the groups
at 5.5.11 The sample size required was n= 76 for each group
(receiving reassurance or not). We took into consideration
an estimated loss to 3-month follow-up of around 40%,
based on a large and relevant study conducted by the World
Health Organization,30 thus aimed to recruit 315 patients.
Statistical Analyses
All analyses were performed using SPSS version 21.31
Assumptions for normality for each of the variables were
examined via the skewness and kurtosis values (where values
that deviate from 0 suggest a non-normal distribution) and
histograms.
Hypotheses 1 and 2 ([1] Reassurance Will be
Associated With LBP Outcomes; [2] Cognitive
Reassurance With Improved Disability, Affective
Reassurance Satisfaction and Enablement, But
Not Disability)
Linear regression models were performed with all
reassurance components entered as a block into the regres-
sion as a predictor of each outcome (satisfaction and ena-
blement at the ﬁrst consultation, and anxiety, depression,
pain and disability scores at 3-month follow-up). Both
unadjusted and adjusted models were performed, with the
adjusted models including confounders entered in 3 blocks
before the reassurance components were included in the
model. The confounders adjusted for were age, sex, educa-
tion, sex congruence of patient with physician, length of
current pain episode, and number of previous consultation
(block 1), pain intensity and disability at baseline (block 2),
and dichotomized psychosocial risk score at baseline (block
3). A score of 0 to 2 indicating low risk and a score of 3 to 4
indicating high risk.
Hypothesis 3 (Psychological Risk Status Moderates
the Reassurance and LBP Outcomes Relationship)
Means and SDs of 3-month LBP outcome scores were
examined when participants were split into high or low
psychosocial risk and low, medium, or high perception of
reassurance (reassurance variables were split into tertiles
based on score percentages (thirds). Interaction term varia-
bles were created that could then be included in linear
regression models (reassurance component×psychological
risk score). Linear regression models were then run for each
of the outcomes listed for objectives 1 and 2, with predictors
again entered in blocks (reassurance component [1= low
perceived reassurance; 2=medium perceived reassurance;
3= high perceived reassurance] and dichotomized psycho-
logical risk score [0= low risk; 1= high risk] [block 1] and
the interaction term [block 2]). This was to test the strength
of association of the main effect of each variable before the
strength of association of the interaction between them. To
reduce multiple testing we limited the analysis to 3-month
outcomes only (disability, pain, depression, and anxiety).
Sensitivity Analysis
High levels of missing data at 3-month follow-up
(between 45% and 56% for each of the 3-month follow-up
variables) and the large numbers of variables controlled for
in objectives 1 and 2 meant that the analysis in the adjusted
linear regression models could be underpowered. Single
imputation was therefore carried out using expectation
maximization imputation. This method assumes data are
missing at random, which was checked using the Little
missing completely at random (MCAR) test32 which will be
nonsigniﬁcant if the data are MCAR. Analyses on the
imputed data are given in Appendix 1 (Supplemental Digital
Content 1, http://links.lww.com/CJP/A454) as a sensitivity
analysis to allow comparison of results between the original
and imputed data sets.
RESULTS
Sample Participants
In total, 318 participants provided responses to the ﬁrst
questionnaire, of which 34.3% scored as high risk (3 to 4 on
the STarT Back tool). Of these, 142 (44.7%) completed the
3-month follow-up questionnaire. Descriptive statistics for
the sample can be found in Table 1. There were only 2
factors in which responders and nonresponders differed.
Those who completed the follow-up assessment were slightly
older (58.1 y, SD 15.0) than those who did not (52.3 y, SD
17.0), and were more likely to have seen a female practi-
tioner (Table 1). The median total scores on each of the
reassurance subscales were as follows: information gather-
ing, 15.5 (interquartile range [IQR], 12, 18); relationship-
building, 17.0 (IQR, 12, 20); generic reassurance was 12.0
(IQR, 7, 16); and cognitive reassurance, 14.0 (IQR, 10, 18)
(Table 2). Kurtosis values for generic reassurance, total
enablement score, and 3-month pain intensity score sug-
gested some deviation from normality in these variables.
The histograms also suggested that most of the included
variables did not follow a normal distribution.
Hypotheses 1 and 2 ([1] Reassurance Will be
Associated With LBP Outcomes; [2] Cognitive
Reassurance With Improved Disability, Affective
Reassurance Satisfaction and Enablement, But
Not Disability)
Regression parameter estimates from the linear
regression analyses are presented in Table 3. For all types of
reassurance, greater perceived reassurance was strongly
associated with greater patient’ satisfaction; increased
generic reassurance was associated with increased enable-
ment, and associated with reduced pain and disability scores
at 3-month follow-up in the unadjusted analysis but once
adjusted the relationship only remained for increased ena-
blement and reduced pain intensity. Increased cognitive
reassurance was associated with increased patient sat-
isfaction and reduced pain scores at 3-month follow-up in
both the unadjusted and adjusted analyses. The R2 change
values suggest that when all reassurance components were
considered together, they were most important for sat-
isfaction and enablement outcomes, accounting for 69% and
29% of the variance, respectively, in the adjusted analyses,
and accounted for very little variance for the 3-month out-
comes (between 1% to 8% [adjusted analyses]). Therefore,
the hypothesis that reassurance (all components) would be
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associated with outcomes is partially supported; and the
hypothesis that cognitive reassurance only will be associated
with disability and that affective reassurance will be
associated with patient satisfaction was also partially sup-
ported (cognitive reassurance was not associated with dis-
ability outcome and while information gathering and rela-
tionship-building reassurance were associated with increased
patient satisfaction, cognitive reassurance was also asso-
ciated with this outcome). In the adjusted imputed analyses,
there were signiﬁcant associations between relationship-
building reassurance and increased enablement, generic
reassurance and reduced disability, cognitive reassurance
and increased anxiety, and information-gathering reassurance
and reduced anxiety. However, the analysis of imputed data
yielded very similar amount of variance explained by the
models to that found in the original data, although some.
Correlations between patient enablement scores at
consultation and outcomes at 3 months were run to explore
the most likely moderator (enablement) between perceived
reassurance and outcomes at 3 months. Enablement was
found to have only very weak associations with all outcomes
(the Pearson correlation coefﬁcients of −0.04 with pain
intensity; −0.09 with disability; −0.07 with depression; and
0.00 with anxiety).
Hypothesis 3 (Psychological Risk Status
Moderates the Reassurance and LBP Outcomes
Relationship)
Table 4 shows the linear regression analyses for
Hypothesis 3, which show the interactions between psy-
chosocial risk and type of reassurance. A statistically sig-
niﬁcant relationship was found for the interaction between
generic reassurance and psychological risk for depression
score at 3-month follow-up. The change in R2 values sug-
gested that the interaction between generic reassurance and
psychological risk results in a 3% increase in variation
explained over and above the main effects of the psycho-
logical risk and generic reassurance variables individually.
Figure 3 illustrates the interaction: although higher scores in
perceived generic reassurance are associated with reductions
in depression for low-risk patients, the opposite is found for
high-risk patients. For these, the more generic reassurance
they perceive to have received, the higher their rates of
depression at 3 months. No other statistically signiﬁcant
interactions were found for any outcome. Similarly, analysis
of imputed data did not ﬁnd a statistically signiﬁcant
interaction (Appendix 1, Supplemental Digital Content 1,
http://links.lww.com/CJP/A454).
TABLE 1. Participant Characteristics
Entire Sample
(n= 318)
3-Month
Responders
(n= 142)
Average age (y) Mean 54.89
(SD 16.4)
Mean 58.09
(SD 14.95)
Sex (n [%])
Female 203 (63.8) 94 (66.2)*
Male 112 (35.2) 48 (33.8)
Unknown 3 (0.9) —
Work status (n [%])
Employed (full or
part time)
173 (54.4 ) 76 (53.5)
Retired 107 (33.6) 55 (38.7)
Looking after
home/family
11 (3.5) 4 (2.8)
Unemployed (health
reasons)
9 (2.8) 2 (1.4)
Unemployed (other) 8 (2.5) 3 (2.1)
Student 8 (2.5) 2 (1.4)
Unknown 2 (0.6) —
Education level (n [%])
Obtained higher
education degree/
certiﬁcation
143 (45.0) 65 (45.8)
Obtained A levels or
equivalent
59 (18.6) 28 (19.7)
Left school at or before 16 102 (32.1) 47 (33.1)
Unknown 14 (4.4) 2 (1.4)
Marital status (n [%])
Married/civil partnership 196 (61.6) 97 (68.3)
Cohabiting 28 (8.8) 8 (5.6)
Single 35 (11.0) 12 (8.5)
Divorced 35 (11.0) 14 (9.9)
Widowed 17 (5.3) 8 (5.6)
Other 4 (1.3) 2 (1.4)
Unknown 3 (0.9) 1 (0.7)
Clinician type (n [%])
General practitioner 305 (95.9) 138 (97.2)
Nurse practitioner 7 (2.2) 3 (2.1)
Unknown 6 (1.9) 1 (0.7)
Clinician sex (n [%])
Female 151 (47.5) 75 (52.8)*
Male 160 (50.3) 65 (45.8)
Unknown 7 (2.2) 2 (1.4)
First episode? (n [%])
Yes 83 (26.1) 41 (28.9)
No 231 (72.6) 101 (71.1)
Unknown 4 (1.3) —
Length of current episode (n [%])
< 1mo 87 (27.4) 41 (28.9)
1-3 mo 76 (23.9) 34 (23.9)
4-6 mo 36 (11.3) 18 (12.7)
7 mo-3 y 58 (18.2) 26 (18.3)
> 3 y 49 (15.4) 22 (15.5)
Unknown 12 (3.8) 1 (0.7)
No. consultations for this episode (n [%])
0 129 (40.6) 57 (40.1)
1-2 80 (25.2) 29 (20.4)
3-10 35 (11.0) 22 (15.5)
> 10 10 (3.1) 6 (4.2)
Unknown 64 (20.1) 28 (19.7)
*P< 0.05.
TABLE 2. Means and SDs for All Variables Included in Analysis
Baseline Median
(IQR)
3 mo Follow-up
Median (IQR)
Reassurance
Information gathering 15.50 (12-18) —
Relationship building 17.00 (12-20) —
Generic 12.00 (7-16) —
Cognitive 14.00 (10-18) —
Disability (RMDQ, 0-24) 10.0 (5-14) 3 (1-9)
Pain intensity (0-10) 7.0 (6-8) 3.0 (1-6)
Patient enablement (PEI) 1 (0-4) —
Patient satisfaction (CSQ) 550.00 (400-700) —
Depression (HADS-D) (0-21) — 3.50 (1-7)
Anxiety (HADS-A) (0-21) — 5.00 (3-9)
CSQ indicates Consultation Satisfaction Questionnaire; HADS, Hospital
Anxiety and Depression Scale; IQR, interquartile range; PEI, Patient Ena-
blement Instrument; RMDQ, Roland-Morris Disability Questionnaire.
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DISCUSSION
The ﬁndings from this study suggest that reassuring
behaviors from GP have an impact on patient’ outcomes. In
addition, it seems that the type of reassurance provided
could be of importance in people with higher psychological
risk. The ﬁndings provide support for the hypothesis that
patient’ perceptions of reassuring behaviors by their doctors
during consultations are associated with some patient’ out-
comes, most notably increased patient satisfaction. Fur-
thermore, the ﬁndings suggest that the relationship between
perceived reassurance and LBP outcomes is moderated by
patients’ psychological risk proﬁle, but only in reference to
reported depression at 3-month follow-up and not with pain,
disability, or anxiety.
Generic reassurance was signiﬁcantly associated with
increased sense of enablement after the consultation, and
with a small decrease in reported pain at 3 months. It might
reﬂect doctors’ ability to detect patients who are most likely
to recover, but this explanation seems limited, because (1)
the association does not extend to disability at 3 months and
(2) there is a signiﬁcant interaction with patients’ risk pro-
ﬁle, discussed below. It is surprising that higher rates of
reported enablement are not associated with better out-
comes, but this is in line with the model of reassurance
proposed by Coia and Morley,14 who argue that generic
reassurance results in immediate reduction of health-related
anxiety, but that sense of reassurance is dependent on the
clinicians’ presence. When the problem rearises, the patient
has acquired no new tools to deal with it. However, it is also
possible that the measure of enablement captures a more
transient experience, or that the measure of enablement is
particularly susceptible to demand characteristics.
Contrary to our prediction, cognitive reassurance was
associated with increased pain at follow-up (albeit with a
low level of predicted variance). This association may be
explained by practitioners utilizing their skills and experi-
ence to predict likely prognosis (see above), therefore
offering more positive messages to those who they think will
improve, and spending more time providing cognitive
reassurance to more complex patients, who might recover
more slowly. Without a record of what was actually said
within the consultation, we can only speculate on the con-
tent of the cognitive reassurance received by patients in this
sample. That cognitive reassurance was associated with any
worse patient outcomes is surprising, as a large body of
existing literature suggests that explanations are valued by
patients, address their concerns, and help them to
recover.12,33–35 It may be the case that the reassurance
provided to participants was not sufﬁcient to have a positive
effect. Within the limited time available for GP
consultations,36 this level of intervention might not be pos-
sible. There is evidence that GPs tend to stick closely to
biomedical explanations, without exploring the psychosocial
context of a patient’s problems.37,38 Thus, patients reported
that they received explanations, but we failed to ask them if
they agreed with these explanations, or continued to believe
that there was a different serious and threatening process
going on within their spine.
We note that adequate provision for psychologically
at-risk patients may still be wanting in primary care: a large
proportion of our cohort were classiﬁed as at-risk, and
according to recommendations,39 should have been referred
to multidisciplinary interventions, and therefore excluded
from the study. Within the stratiﬁed model of care advo-
cated by the developers of the STarT Back tool,28 more
intensive psychological intervention is recommended for
high-risk patients.40
The Interaction Between Risk Profile,
Reassurance, and Outcomes
The ﬁndings suggest an interaction between generic
reassurance and patient’ risk in association with depression at
3 months. Although low-risk patients who received generic
messages about likely recovery had the lowest rates of
TABLE 3. Reassurance as a Predictor of Outcomes Postconsultation and at 3-Month Follow-up; Regression Analysis
Statistics Reassurance Model Satisfaction (n= 312; 228†) Enablement (n= 312; 228†)
Unadjusted
B (SE, 95% CI) Information gathering 10.56 (2.37, 5.91-15.22)* 0.05 (0.06, −0.07 to 0.17)
b (P) 0.24 (P< 0.05)* 0.07 (P= 0.07)
B (SE, 95% CI) Relationship building 17.15 (2.28, 12.66-21.64)* 0.11 (0.06, −0.00 to 0.23)
b (P) 0.43 (P< 0.05)* 0.18 (P= 0.05)
B (SE, 95% CI) Generic 1.07 (1.35, −1.58 to 3.72) 0.14 (0.03, 0.07-0.21)*
b (P) 0.03 (P= 0.43) 0.25 (P< 0.05)*
B (SE, 95% CI) Cognitive 7.85 (2.17, 3.58-12.12)* 0.07 (0.06, −0.04 to 0.18)
b (P) 0.21 (P< 0.05)* 0.12 (P= 0.20)
R2 change 0.71 (P< 0.05)* 0.28 (P< 0.05)*
Adjusted†
B (SE, 95% CI) Information gathering 10.12 (2.66, 4.88-15.36)* 0.03 (0.07, −0.12 to 0.17)
b (P) 0.23 (P≤ 0.05)* 0.04 (P= 0.72)
B (SE, 95% CI) Relationship building 13.22 (2.52, 8.25-18.19)* 0.14 (0.07, −0.00 to 0.27)
b (P) 0.34 (P≤ 0.05)* 0.21 (P= 0.06)
B (SE, 95% CI) Generic 4.00 (1.55, 0.94-7.06)* 0.14 (0.04, 0.05-0.22)*
b (P) 0.12 (P= 0.01)* 0.23 (P= 0.00)*
B (SE, 95% CI) Cognitive 9.58 (2.46, 4.73-14.44)* 0.10 (0.07, −0.04 to 0.23)
b (P) 0.26 (P≤ 0.05)* 0.16 (P= 0.15)
R2 change 0.69 (P≤ 0.05)* 0.29 (P< 0.05)*
†Adjusted for age, sex, education, sex congruence with clinician, episode length, previous consultations, baseline pain intensity, baseline disability, and STarT
Back tool risk score.
CI indicates conﬁdence interval.
*P< 0.05.
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depression, the opposite was found for patients at high risk
despite the fact that these patients reported reductions in pain.
For these high-risk patients such messages were associated
with higher rates of depression, possibly because they failed to
address their catastrophic thinking, or, because the reassur-
ance was perceived as being false when the pain did not
improve as much they expected or were led to hope.
Strengths and Limitations
This is the ﬁrst prospective cohort study to use a validated
measure of perceived reassurance for LBP. Previous research has
inferred reassurance from patients’ outcomes, for example, see
Traeger et al41 or measured proximal consultation processes.3
The questionnaire utilized in this study has been speciﬁcally
validated in LBP populations and has been shown to reliably
measure patients’ perceptions of reassurance.11 In addition, this
is the ﬁrst study to examine the impact of reassurance on dif-
ferent subgroups of LBP patients. This study therefore provides
the ﬁrst step into understanding what can be done to reassure
patients with varying psychological risk proﬁles.
However, the study ﬁndings should be viewed with
caution due to several limitations. The response rate fell
short of the expected 60%, and resulted in possible under-
powering to detect interactions for some outcomes. The
sensitivity analysis on imputed data did identify some dif-
ferences between the ﬁndings in the original and imputed
data, and the Little MCAR test indicated that the data were
not missing at random, suggesting there is a potential for
bias. Another potential limitation of the study is that par-
ticipants provided recall up to 1 month following their care
visit, and this recall may be confounded by changes in
symptoms and other care experiences that occurred within
the 1-month period. In addition we did not power the study
to test the signiﬁcance in speciﬁc subgroups, to further
explain signiﬁcant interactions, and strongly propose that
future research does so. We also note that measures of mood
was only taken at the 3-month follow-up. A stronger design
would include both these variables at baseline.
The search strategy meant that more complex cases of
LBP, which had been referred on to other specialists, were
not included. Reassuring behaviors for these patients,
therefore, are not represented in this study. In addition, the
follow-up period in this study was only 3 months. Future
studies should recruit samples that include more complex
cases, and measure the long-term effects of reassurance on
patients’ outcomes. An ideally designed study would have
baseline data collected preconsultation, and postconsultation
measures (including reassurance) collected directly after the
consultation to avoid recall bias. We could not do so,
because of ethical restraints on questioning patients about
their reasons for consulting before the consultation, and
providing at least 48 hours to consider whether they agreed
to take part in the study. We were also unable to measure the
number of patients identiﬁed for the study: our original
design required clinical staff (who due to ethical require-
ments are the only personnel with access to patients records)
to keep and report numbers, but in practice, in busy sur-
geries, staff were not able to do so reliably.
The reassurance measure used in this study relies on
patient self-report, which is based on their perceptions of what
happened during a consultation. Although this is valuable
information, it may not reﬂect the consultation reliably.
Future research in which patients’ perceptions of reassurance
are measured alongside direct observation of consultations will
allow testing whether physicians’ attempts at reassurance are,
in fact, recognized by (all) patients, and what the implications
are when reassurance is not perceived, or is not offered.
We included only 4 items from the validated STarT
Back tool psychological subscale, and so chose an mid-point
cut-point for classifying patients into high/low-risk sub-
groups. We note that the single items on the STarT Back
represent strongly evident risk factors, and that there is
considerable evidence that the more of these are endorsed by
TABLE 3. (Continued)
Pain Intensity (n= 140; 110†) Disability (n= 138; 109†) Depression (n= 139; 109†) Anxiety (n= 139; 109†)
Unadjusted
−0.03 (0.10, −0.23 to 0.17) 0.04 (0.20, −0.35 to 0.44) −0.10 (0.14, −0.37 to 0.17) −0.15 (0.17, −0.48 to 0.17)
−0.05 (P= 0.75) 0.03 (P= 0.83) −0.11 (P= 0.47) −0.14 (P= 0.35)
−0.08 (0.09, −0.26 to 0.11) −0.09 (0.19, −0.46 to 0.29) 0.03 (0.13, −0.23 to 0.28) −0.07 (0.16, −0.38 to 0.24)
−0.13 (P= 0.41) −0.08 (P= 0.64) 0.03 (P= 0.84) −0.07 (P= 0.67)
−0.16 (0.06, −0.27 to −0.05)* −0.23 (0.11, −0.46 to −0.01)* −0.12 (0.08, −0.28 to 0.03) −0.09 (0.09, −0.28 to 0.10)
−0.31 (P= 0.01)* −0.23 (P= 0.04)* −0.18 (P= 0.12) −0.11 (P= 0.35)
0.24 (0.08, 0.08-0.39)* 0.16 (0.16, −0.16 to 0.47) 0.13 (0.11, −0.08 to 0.35) 0.25 (0.13, −0.01 to 0.50)
0.42 (P= 0.00)* 0.14 (P= 0.33) 0.18 (P= 0.22) 0.27 (P= 0.06)
0.10 (P= 0.01)* 0.04 (P= 0.25) 0.03 (P= 0.44) 0.03 (P= 0.37)
Adjusted†
−0.07 (0.09, −0.25 to 0.12) −0.09 (0.17, −0.43 to 0.26) −0.24 (0.14, −0.51 to 0.03) −0.27 (0.15, −0.58 to 0.31)
−0.10 (P= 0.47) −0.07 (P= 0.62) −0.27 (P= 0.08) −0.26 (P= 0.08)
−0.04 (0.09, −0.22 to 0.14) 0.04 (0.17, −0.29 to 0.37) 0.22 (0.13, −0.04 to 0.47) −0.19 (0.15, −0.10 to 0.48)
−0.07 (P= 0.64) 0.04 (P= 0.79) 0.27 (P= 0.10) −0.20 (P= 0.20)
−0.14 (0.06, −0.26 to −0.03)* −0.07 (0.11, −0.29 to 0.14) 0.02 (0.08, −0.15 to 0.18) 0.05 (0.09, −0.14 to 0.23)
−0.27 (P= 0.02)* −0.07 (P= 0.51) 0.02 (P= 0.86) 0.06 (P= 0.63)
0.27 (0.08, 0.12-0.43)* 0.14 (0.15, −0.16 to 0.44) 0.01 (0.12, −0.22 to 0.24) 0.07 (0.13, −0.19 to 0.33)
0.49 (P= 0.00)* 0.13 (P= 0.36) 0.02 (P= 0.92) 0.08 (P= 0.62)
0.08 (P= 0.01)* 0.01 (P= 0.84) 0.03 (P= 0.37) 0.03 (P= 0.34)
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patients, the higher the risk for poor prognosis. Although
our classiﬁcation may have lacked sensitivity, it is likely to
result in our failure to detect existing associations, rather
than in a type 1 error.
Implications
The ﬁndings from this study, in combination with
mounting evidence from other studies, suggests that reas-
suring behaviors from GP could be improved to have
impact on patient’ outcomes. Of importance, such behaviors
should be studied to improve reassurance in people with
higher psychological risk. Current guidelines2 that recom-
mend delivery of reassurance fall short of advising on the
content, and method of delivery, or tailoring of such
reassurance.
A systematic review42 of 12 qualitative (n= 490) and 8
quantitative (n= 3755) studies summarized evidence from
studies with LBP patients on their expectations and sat-
isfaction with treatment. The review suggested that patients
were mostly dissatisﬁed with the amount of information
provided by their practitioner. The review concludes that
practice guidelines should include instructions on how to
discuss the causes and diagnosis with the patient; however,
to date such guidelines have not been produced.
The ﬁndings conﬁrm that different reassuring behav-
iors are associated with different outcomes. Future research
is needed to clarify the effect of generic reassurance, espe-
cially when offered to patients who present with psycho-
logical obstacles to recovery. There is evidence suggesting
that these behaviors lead to better patient outcomes.43 This
study offers the ﬁrst evidence suggesting that offering such
reassurance to more complex patients might actually result
in worse outcomes, at least in reference to low mood.
Relationship building and appropriate levels of data col-
lection might also be improved, as they were not associated
in this study with improved outcomes, although they were
strongly associated with patient’ satisfaction. The patient-
centeredness movement is built on the notion that physicians
should aim to understand a patient’s whole situation and
build a therapeutic relationship,35 and, indeed, a number of
previous studies44,45 have conﬁrmed that patients value
these behaviors. There is evidence that patients with LBP
value emotionally reassuring behaviors, particularly inter-
personal behaviors that display caring, empathy and
warmth; however, the provision of clear explanations was
rated as the most reassuring aspect of the consultation.12
How to provide clear explanations, and adjust these in the
context of uncertainty to match individual patients’ needs
remain a challenge, and should form a priority for future
research. The current study offers some evidence, but it was
underpowered for subgroup analysis for risk, and the ﬁnd-
ings must therefore be viewed with caution. Future studies
should consider subgroups a-priori and plan for sufﬁcient
power to test the interactions between psychological risk
and reassurance styles. Until such work is carried out the
clinical utility of existing studies, including this one, remain
limited.
In conclusion, we offer preliminary evidence that
current provision of reassurance for people consulting for
LBP improves satisfaction and fosters a short-term sense of
enablement, but this does not translate into better outcomes
at follow-up. In addition, at present, people with psycho-
logical risk proﬁles are not adequately identiﬁed or
reassured.
TABLE 4. Main Effects and Interactions Between Reassurance and Risk
Statistics Model Pain Intensity (n= 143)
B (SE, 95% CI) Information gathering 0.03 (0.07, −0.10 to 0.16)
b (P) 0.05 (P= 0.65)
B (SE, 95% CI) Psychological risk 2.31 (1.78, −1.20 to 5.81)
b (P) 0.38 (P= 0.20)
B (SE, 95% CI) Information-gathering psychological risk* −0.04 (0.12, −0.27 to 0.19)
b (P) −0.09 (P= 0.75)
R2 change 0.00 (P= 0.75)
B (SE, 95% CI) Relationship building −0.01 (0.06, −0.13 to 0.12)
b (P) −0.01 (P= 0.91)
B (SE, 95% CI) Psychological risk 1.02 (1.60, −2.15 to 4.19)
b (P) 0.17 (P= 0.53)
B (SE, 95% CI) Relationship-building psychological risk* 0.05 (0.10, −0.15 to 0.25)
b (P) 0.13 (P= 0.62)
R2 change 0.00 (P= 0.62)
B (SE, 95% CI) Generic −0.11 (0.05, −0.22 to −0.01)*
b (P) −0.22 (P= 0.03)*
B (SE, 95% CI) Psychological risk 0.11 (1.12, −2.10 to 2.32)
b (P) 0.02 (P= 0.92)
B (SE, 95% CI) Generic psychological risk* 0.14 (0.09, −0.04 to 0.33)
b (P) 0.29 (P= 0.12)
R2 change 0.02 (P= 0.12)
B (SE, 95% CI) Cognitive 0.03 (0.06, −0.09 to 0.14)
b (P) 0.05 (P= 0.64)
B (SE, 95% CI) Psychological risk 0.23 (1.36, −2.46 to 2.93)
b (P) 0.04 (P= 0.87)
B (SE, 95% CI) Cognitive psychological risk* 0.12 (0.09, −0.07 to 0.30)
b (P) 0.29 (P= 0.22)
R2 change 0.01 (P= 0.22)
*P < 0.05.
CI indicates conﬁdence interval.
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TABLE 4. (Continued)
Disability (n= 141) Depression (n= 142) Anxiety (n= 142)
0.08 (0.12, −0.16 to 0.32) −0.04 (0.09, −0.21 to 0.13) 0.03 (0.10, −0.17 to 0.23)
0.06 (P= 0.52) −0.05 (P= 0.62) −0.17 (P= 0.54)
7.61 (3.30, 1.10-14.13) 1.40 (2.29, −3.13 to 5.94) 5.62 (2.69, 0.31-10.94)*
0.64 (P= 0.02)* 0.18 (P= 0.54) 0.58 (P= 0.04)*
−0.18 (0.22, −0.61 to 0.25) 0.10 (0.15, −0.20 to 0.40) −0.11 (0.18, −0.45 to 0.24)
−0.23 (P= 0.40) 0.19 (P= 0.50) −0.17 (P= 0.54)
0.00 (P= 0.40) 0.00 (P= 0.50) 0.01 (P= 0.54)
−0.01 (0.12, −0.24 to 0.23) 0.01 (0.08, −0.16 to 0.17) 0.06 (0.10, −0.13 to 0.25)
−0.01 (P= 0.96) 0.01 (P= 0.93) 0.06 (P= 0.53)
5.20 (2.98, −0.70 to 11.10) 2.33 (2.08, −1.78 to 6.43) 5.16 (2.43, 0.35-9.97)*
0.44 (P= 0.08) 0.29 (P= 0.27) 0.54 (P= 0.04)*
−0.02 (0.19, −0.39 to 0.35) 0.04 (0.13, −0.22 to 0.30) −0.07 (0.15, −0.37 to 0.23)
−0.03 (P= 0.92) 0.08 (P= 0.76) −0.11 (P= 0.65)
0.00 (P= 0.92) 0.00 (P= 0.76) 0.00 (P= 0.65)
−0.20 (0.10, −0.39 to −0.02)* −0.14 (0.07, −0.27 to −0.01)* −0.04 (0.08, −0.20 to 0.11)
−0.20 (P= 0.04)* −0.21 (P= 0.03)* −0.05 (P= 0.59)
2.45 (2.09, −1.68 to 6.58) −0.21 (1.44, −3.06 to 2.63) 3.38 (1.72, −0.03 to 6.78)
0.21 (P= 0.24) −0.03 (P= 0.88) 0.35 (P= 0.05)
0.21 (0.17, −0.13 to 0.53) 0.27 (0.12, 0.04-0.49)* 0.06 (0.14, −0.21 to 0.33)
0.22 (P= 0.22) 0.42 (P= 0.02)* 0.08 (P= 0.66)
0.01 (P= 0.22) 0.03 (P= 0.02)* 0.00 (P= 0.66)
−0.06 (0.11, −0.27 to 0.16) −0.03 (0.07, −0.18 to 0.11) 0.07 (0.09, −0.10 to 0.24)
−0.05 (P= 0.60) −0.04 (P= 0.66) 0.08 (P= 0.44)
3.06 (2.57, −2.02 to 8.15) 0.77 (1.78, −2.74 to 4.28) 3.98 (2.09, −0.14 to 8.11)
0.26 (P= 0.24) 0.10 (P= 0.67) 0.41 (P= 0.06)
0.14 (0.18, −0.21 to 0.49) 0.16 (0.12, −0.08 to 0.40) 0.10 (0.14, −0.27 to 0.29)
0.17 (P= 0.44) 0.29 (P= 0.20) 0.01 (P= 0.95)
0.00 (P= 0.44) 0.01 (P= 0.20) 0.00 (P= 0.95)
FIGURE 3. The interaction between reassurance and risk profile on anxiety at follow-up. HADS indicates Hospital Anxiety and
Depression Scale. SB indicates StarTBack items.
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